Scheer Maximilian, Simmermacher Sebastian, Prell Julian, Leisz Sandra, Scheller Christian, Mawrin Christian, Strauss Christian, Rampp Stefan
Department of Neurosurgery, Medical Faculty, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Department of Neuropathology, University Magdeburg, Magdeburg, Germany.
Front Surg. 2023 Jun 21;10:1216093. doi: 10.3389/fsurg.2023.1216093. eCollection 2023.
The treatment approach of vestibular schwannoma (VS) has seen a change in recent years, with a trend away from radical surgery towards preservation of cranial nerve function. A recent study reported recurrences as long as 20 years after complete removal of VS.
To report the risk of recurrence and progression in our patient population the authors retrospectively reviewed outcomes of patients.
Cases with unilateral VS who had undergone primary microsurgery via retrosigmoidal approach between 1995 and 2021 were investigated. Complete tumor removal was defined as gross total resection (GTR), a capsular remnant was categorized as near total resection (NTR) and residual tumor was designated as subtotal resection (STR). The primary endpoint was radiological recurrence-free survival.
386 patients fulfilled the inclusion criteria of the study and were evaluated. GTR was achieved in 284 patients (73.6%), NTR was achieved in 63 patients (10.1%) and STR was present in 39 patients (16.3%). A total of 28 patients experienced recurrences with significant differences in the three subgroups. The strongest predictor of recurrence was the extent of resection, with patients who underwent STR having an almost 10-fold higher risk of recurrence and patients who had undergone NTR having an almost 3-fold higher risk than those treated with GTR. More than 20% of recurrences (6/28) occured after more than 5 years.
The degree of resection is an important guide to the interval of follow-up, but long-term follow-up should be considered also in the case of GTR. The majority of recurrences occurs after 3-5 years. Nevertheless, a follow-up of at least 10 years should be carried out.
近年来,前庭神经鞘瘤(VS)的治疗方法发生了变化,出现了从根治性手术转向保留颅神经功能的趋势。最近一项研究报告称,VS完全切除后长达20年仍有复发情况。
为报告作者所在患者群体中的复发和进展风险,对患者的结局进行了回顾性研究。
对1995年至2021年间经乙状窦后入路接受初次显微手术的单侧VS病例进行调查。完全肿瘤切除定义为全切除(GTR),有包膜残留归类为近全切除(NTR),残留肿瘤指定为次全切除(STR)。主要终点是影像学无复发生存期。
386例患者符合研究纳入标准并接受评估。284例患者实现了GTR(73.6%),63例患者实现了NTR(10.1%),39例患者存在STR(16.3%)。共有28例患者复发,三个亚组存在显著差异。复发的最强预测因素是切除范围,接受STR的患者复发风险几乎高出10倍,接受NTR的患者复发风险比接受GTR的患者高出近3倍。超过20%的复发(6/28)发生在5年以上。
切除程度是随访间隔的重要指导,但即使是GTR的情况也应考虑长期随访。大多数复发发生在3 - 5年后。尽管如此,仍应进行至少10年的随访。